Form 4 for TECX Tectonic Therapeutic, Inc.
Accepted 2022-12-28 00:00:00 ET · period of report 2022-12-23 · accession 0001127602-22-028329 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-28 | 2022-12-23 | TECX | MACKAY GEOFFREY | Pres, CEO, Dir | M - OptEx | $0.41 | +142.0K | 387.1K | +58% | +$58.2K |
| D | 2022-12-28 | 2022-12-23 | TECX | MACKAY GEOFFREY | Pres, CEO, Dir | M - OptEx | $0.00 | -142.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-23 | M | A | 142,013 | $0.41 | 387,136 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-12-23 | M | D | 142,013 | $0.00 | 0 | D | $0.41 · — to 2026-04-12 | 142,013 Common Stock | (F1) 25% of the shares vested on July 1, 2017, and the remaining 75% vested in equal quarterly installments thereafter over a three-year period. |